Wells Fargo’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$688K Sell
74,150
-2,895
-4% -$26.9K ﹤0.01% 3583
2025
Q1
$565K Buy
77,045
+2,837
+4% +$20.8K ﹤0.01% 3600
2024
Q4
$634K Sell
74,208
-382,218
-84% -$3.26M ﹤0.01% 3571
2024
Q3
$3.97M Buy
456,426
+405,107
+789% +$3.52M ﹤0.01% 2285
2024
Q2
$351K Buy
51,319
+15,280
+42% +$105K ﹤0.01% 3791
2024
Q1
$328K Buy
36,039
+13,836
+62% +$126K ﹤0.01% 3815
2023
Q4
$99K Buy
22,203
+5,078
+30% +$22.6K ﹤0.01% 4504
2023
Q3
$53.8K Sell
17,125
-17,388
-50% -$54.6K ﹤0.01% 4796
2023
Q2
$178K Buy
34,513
+16,724
+94% +$86.3K ﹤0.01% 4399
2023
Q1
$93.7K Buy
17,789
+15,839
+812% +$83.5K ﹤0.01% 4557
2022
Q4
$5.48K Sell
1,950
-4,562
-70% -$12.8K ﹤0.01% 5414
2022
Q3
$27K Sell
6,512
-605
-9% -$2.51K ﹤0.01% 4938
2022
Q2
$29K Sell
7,117
-9,103
-56% -$37.1K ﹤0.01% 4992
2022
Q1
$80K Sell
16,220
-25,816
-61% -$127K ﹤0.01% 5107
2021
Q4
$292K Sell
42,036
-14,450
-26% -$100K ﹤0.01% 4709
2021
Q3
$565K Sell
56,486
-15,825
-22% -$158K ﹤0.01% 4343
2021
Q2
$1.03M Sell
72,311
-463,021
-86% -$6.56M ﹤0.01% 3973
2021
Q1
$8.79M Buy
535,332
+232,689
+77% +$3.82M ﹤0.01% 2219
2020
Q4
$6.26M Buy
302,643
+135,832
+81% +$2.81M ﹤0.01% 2499
2020
Q3
$1.27M Buy
166,811
+98,612
+145% +$750K ﹤0.01% 3606
2020
Q2
$568K Buy
68,199
+15,271
+29% +$127K ﹤0.01% 4119
2020
Q1
$262K Sell
52,928
-1,858
-3% -$9.2K ﹤0.01% 4345
2019
Q4
$216K Sell
54,786
-293
-0.5% -$1.16K ﹤0.01% 4756
2019
Q3
$168K Buy
55,079
+24,254
+79% +$74K ﹤0.01% 4864
2019
Q2
$136K Sell
30,825
-2,936
-9% -$13K ﹤0.01% 4959
2019
Q1
$134K Sell
33,761
-46
-0.1% -$183 ﹤0.01% 4941
2018
Q4
$134K Sell
33,807
-11,239
-25% -$44.5K ﹤0.01% 4928
2018
Q3
$310K Buy
45,046
+12,170
+37% +$83.8K ﹤0.01% 4612
2018
Q2
$222K Sell
32,876
-607
-2% -$4.1K ﹤0.01% 4804
2018
Q1
$218K Sell
33,483
-33,116
-50% -$216K ﹤0.01% 4760
2017
Q4
$296K Sell
66,599
-8,402
-11% -$37.3K ﹤0.01% 4614
2017
Q3
$463K Sell
75,001
-649
-0.9% -$4.01K ﹤0.01% 4266
2017
Q2
$701K Sell
75,650
-11,396
-13% -$106K ﹤0.01% 3913
2017
Q1
$807K Buy
87,046
+17,445
+25% +$162K ﹤0.01% 3834
2016
Q4
$582K Buy
69,601
+30,921
+80% +$259K ﹤0.01% 3989
2016
Q3
$266K Buy
38,680
+752
+2% +$5.17K ﹤0.01% 4161
2016
Q2
$188K Sell
37,928
-6,425
-14% -$31.8K ﹤0.01% 4300
2016
Q1
$429K Buy
44,353
+22,360
+102% +$216K ﹤0.01% 3859
2015
Q4
$206K Buy
21,993
+539
+3% +$5.05K ﹤0.01% 4290
2015
Q3
$302K Buy
21,454
+5,263
+33% +$74.1K ﹤0.01% 4105
2015
Q2
$340K Buy
16,191
+10,299
+175% +$216K ﹤0.01% 4188
2015
Q1
$247K Buy
5,892
+5,625
+2,107% +$236K ﹤0.01% 4204
2014
Q4
$6K Buy
+267
New +$6K ﹤0.01% 5564